Director, Chief Executive Officer · Immunovant, Inc. · Common Stock
Side
A
Value
—
Shares
232.3K
Price
—
Executed
Apr 7, 2026
Disclosed
Apr 9, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 7 executedApr 9, 2026 disclosed
IMVT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 1187.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Venker Eric filed this Form 4 reporting a grant or award of IMVT on Apr 7, 2026. It became public on Apr 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Venker Ericcik:0001801917
Issuer
Immunovant, Inc.cik:0001764013
Revision history · 0
No field has changed since this record was first ingested.
